osteoporosis

Merck Loses $8 Million Verdict in Trial Over Fosamax
Bloomberg Businessweek
Mon, 06/28/10 - 03:05 pm
Merck
Fosamax
osteoporosis
lawsuits
Merck Challenges Verdict in Federal FOSAMAX® (alendronate sodium) Trial
BusinessWire
Sat, 06/26/10 - 09:29 am
Merck
Fosamax
osteoporosis
Amgen’s Bone Drug Wins Positive Review From U.K. Cost Agency
Bloomberg
Fri, 06/18/10 - 11:32 am
Prolia
UK
Amgen
osteoporosis
Amgen Back in the Spotlight
Seeking Alpha
Tue, 06/8/10 - 08:51 am
Amgen
Prolia
prostate cancer
osteoporosis
Amgen's Hopes for Prolia Go Beyond Osteoporosis Therapy
Seeking Alpha
Sun, 06/6/10 - 10:57 am
Amgen
Prolia
osteoporosis
Bone metastases
Amgen's New Osteoporosis Drug: It May Not Fly Under Healthcare Reform
BNET Pharma
Thu, 06/3/10 - 08:55 pm
Amgen
osteoporosis
Prolia
healthcare reform
Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Seeking Alpha
Wed, 06/2/10 - 08:22 am
Amgen
Prolia
osteoporosis
FDA
FDA clears Amgen's bone-strengthening drug, Prolia
Yahoo/AP
Wed, 06/2/10 - 08:21 am
FDA
Prolia
Amgen
GSK
Merck
Zemeta
Fosamax
osteoporosis
EU Approval for Amgen's Prolia
Yahoo/Zacks
Sat, 05/29/10 - 09:28 am
Amgen
Prolia
prostate cancer
osteoporosis
Merck: Jury rules against plaintiff over Fosamax
Yahoo/AP
Wed, 05/5/10 - 09:14 pm
Merck
Fosamax
osteoporosis
Novartis initiates second phase-I trial for oral PTH1-34 to treat postmenopausal osteoporosis
Pharmabiz
Sat, 04/17/10 - 12:53 pm
Novartis
Emisphere
Eligen Technology
PTH1-34
osteoporosis
Bone drugs Fosamax, Reclast prevent more fractures than any they may cause, study suggests
Yahoo/AP
Thu, 03/25/10 - 09:04 am
Reclast
osteoporosis
Fosamax
FDA to Review Bone Drugs After Studies Report Hip Breaks
WSJ Online
Thu, 03/11/10 - 09:05 am
FDA
osteoporosis
Merck
Fosamax
Boning Up on Pfizer's Drug
Forbes
Sat, 02/27/10 - 12:12 pm
Fablyn
Pfizer
Eli Lilly
Evista
osteoporosis
Judge refuses to dismiss Fosamax case, sets trial
Reuters
Mon, 02/1/10 - 10:10 am
osteoporosis
Fosamax
trials
Merck
Timing Is Everything for Amgen
Motley Fool
Tue, 01/26/10 - 05:57 pm
Amgen
Prolia
osteoporosis
Despite FDA Recommendation for Postmarketing Surveillance, Amgen's Prolia Will Achieve Blockbuster Sales for Treatment of Osteoporosis
Trading Markets
Sat, 01/9/10 - 12:49 pm
Prolia
osteoporosis
Amgen
Merck Triumphs in Defense of Osteoporosis Drug...for Now
Seeking Alpha
Fri, 11/27/09 - 10:32 am
Merck
osteoporosis
Fosamax
Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question
BNET Pharma
Tue, 10/20/09 - 10:35 am
Amgen
Prolia
FDA
osteoporosis
denosumab
Amgen: Still Waiting for Its Blockbuster
Motley Fool
Mon, 10/19/09 - 06:33 pm
denosumab
Amgen
Prolia
osteoporosis

Pages